Abstract
ImportancePublished evidence on the long-term safety of etanercept (ETA) and adalimumab (ADA) in patients with polyarticular juvenile idiopathic arthritis (pJIA) is still limited.ObjectivesTo investigate the rates of serious adverse events...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have